PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors

Published:2019-09 Issue:3 Volume:154 Page:531-538
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Tang Monica^ORCID,O'Connell Rachel L.,Amant Frederic,Beale Philip,McNally Orla,Sjoquist Katrin M.,Grant Peter,Davis Alison,Sykes Peter,Mileshkin Linda^ORCID,Moujaber Tania,Kennedy Catherine J.,deFazio Anna,Tan King,Antill Yoland,Goh Jeffrey,Bonaventura Tony,Scurry James,Friedlander Michael

Funder

Cancer Australia

Cancer Council New South Wales

National Health and Medical Research Council

Cancer Institute NSW

Victorian Cancer Agency

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference42 articles.

1. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis;Shih;Am. J. Pathol.,2004

2. The origin and pathogenesis of epithelial ovarian cancer-a proposed unifying theory;Kurman;Am. J. Surg. Pathol.,2010

3. Reclassification of serous ovarian carcinoma by a 2-tier system;Bodurka;Cancer,2012

4. A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978–2006;Hannibal;Gynecol. Oncol.,2012

5. Survival in women with grade 1 serous ovarian carcinoma;Fader;Obstet. Gynecol.,2013

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer;Gynecologic Oncology;2024-10

2. Treatment of recurrent serous borderline tumors with noninvasive peritoneal implants;International Journal of Gynecologic Cancer;2024-09

3. Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics;Frontiers in Oncology;2024-07-15

4. Steroid metabolism and hormonal dynamics in normal and malignant ovaries;Essays in Biochemistry;2024-07-12

5. Molecular changes driving low-grade serous ovarian cancer and implications for treatment;International Journal of Gynecologic Cancer;2024-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3